Patents Assigned to Vectogen Pty Ltd.
  • Recombinant porcine adenovirus vector
    Patent number: 7785602
    Abstract: This invention relates to a recombinant vector including a recombinant porcine adenovirus, stably incorporating and capable of expression of at least one heterologous nucleotide sequence. The nucleotide sequence is preferably one which encodes an antigenic determinant of Hog Cholera Virus or Pseudorabies virus. The further invention relates to a method of production of recombinant vectors, to methods of preparation of vaccines based on the vectors, to administration strategies and to methods of protecting pigs from disease.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: August 31, 2010
    Assignee: Vectogen Pty Ltd.
    Inventors: Michael A. Johnson, Jeffrey Michael Hammond, Richard J. McCoy, Michael G. Sheppard
  • Methods and Compositions for Use of a Coccidiosis Vaccine
    Publication number: 20100150958
    Abstract: The invention relates to new vaccine compositions for vaccinating birds.
    Type: Application
    Filed: November 18, 2009
    Publication date: June 17, 2010
    Applicant: VECTOGEN PTY LTD.
    Inventor: Michael Sheppard
  • PCV 2-Based Methods and Compositions for the Treatment of Pigs
    Publication number: 20100150959
    Abstract: The present invention relates to methods and compositions for vaccinating pigs against porcine circovirus associated diseases.
    Type: Application
    Filed: November 19, 2009
    Publication date: June 17, 2010
    Applicant: VECTOGEN PTY LTD.
    Inventors: Michael Sheppard, Sui T. Lay
  • Recombinant porcine adenovirus vector
    Patent number: 7473428
    Abstract: This invention relates to a recombinant vector including a recombinant porcine adenovirus, stably incorporating and capable of expression of at least one heterologous nucleotide sequence. The nucleotide sequence is preferably one which encodes an antigenic determinant of Hog Cholera Virus or Pseudorabies virus. The further invention relates to a method of production of recombinant vectors, to methods of preparation of vaccines based on the vectors, to administration strategies and to methods of protecting pigs from disease.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: January 6, 2009
    Assignee: VectoGen Pty Ltd.
    Inventors: Michael A. Johnson, Jeffrey Hammond, Richard J. McCoy, Michael G. Sheppard
  • Recombinant porcine adenovirus vector
    Patent number: 7323177
    Abstract: This invention relates to a recombinant vector including a recombinant porcine adenovirus, stably incorporating and capable of expression of at least one heterologous nucleotide sequence. The nucleotide sequence is preferably one which encodes an antigenic determinant of Hog Cholera Virus or Pseudorabies virus. The further invention relates to a method of production of recombinant vectors, to methods of preparation of vaccines based on the vectors, to administration strategies and to methods of protecting pigs from disease.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: January 29, 2008
    Assignee: Vectogen Pty Ltd.
    Inventors: Michael Anthony Johnson, Jeffrey Michael Hammond, Richard J. McCoy, Michael G. Sheppard